Drugs / Flavoxate
last change Dec 2007 re-read 2 minutes ago

Flavoxate

Small molecule

Investigated by
Padagis LLC

Regulatory milestones approvals, filings & regulatory actions · 1 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Approved US (FDA) URISPAS 1970-01-15 fda.gov

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00992238 Padagis LLC Completed No outcome recorded
Also used as a comparator or background therapy in 1 trial
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00440739 Comparator Sep 2005 → Dec 2007 Mahidol University Completed No outcome recorded

Evidence & citations 10 cited values

Every value below carries the sentence it was read from. 3 sources stand behind the page.

FieldValueCited text
Known as Flavoxate ClinicalTrials.gov intervention name — accepted as the source's own label NCT00992238
1

NCT00440739

Known as Bladuril ChEMBL registry synonym — accepted as the source's own label CHEMBL1493
Known as DW-61 ChEMBL registry synonym — accepted as the source's own label CHEMBL1493
Known as Flavoxate hcl ChEMBL registry synonym — accepted as the source's own label CHEMBL1493
Known as Flavoxate Hydrochloride “The purpose of this study is to compare the relative bioavailability of Flavoxate Hydrochloride tablets 100mg manufactured by Paddock Laboratories, Inc., with that of Urispas®...” NCT00992238
Known as Flavoxato ChEMBL registry synonym — accepted as the source's own label CHEMBL1493
Known as NSC-114649 ChEMBL registry synonym — accepted as the source's own label CHEMBL1493
Known as Urispas ChEMBL registry synonym — accepted as the source's own label CHEMBL1493
Known as Urispas 200 ChEMBL registry synonym — accepted as the source's own label CHEMBL1493
Modality Small molecule CHEMBL1493